Back to results
US 12,492,179 B2Granted
Substituted ethylamine fused heterocyclic mescaline derivatives
AssigneeEnveric Biosciences Canada Inc.
InventorsKaveh Matinkhoo, David James Press, Jessica Bik-jing Lee, Ye Cai, Jillian M. Hagel, Peter J. Facchini
Life of this patent
Estimating the term…
Abstract
Disclosed are novel fused mescaline derivative compounds, notably substituted ethylamine fused heterocyclic mescaline derivatives, including substituted ethylamine fused dioxolane mescaline derivatives, and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.
Claims3
A pharmaceutical drug formulation comprising an effective amount of a compound or salt thereof, the compound selected from the group of compounds having the chemical formula:
- Bx(II);
- Bx(IV);
- Bx(V);
- Bx(VI);
- Bx(VII);
- Bx(VIII);
- and By(IX):
- wherein in each of compound Bx(II);
- Bx(IV);
- Bx(V);
- Bx(VI);
- Bx(VII);
- Bx(VIII);
- and By(IX), optionally, the nitrogen atom of the ethylamine portion of each compound may be protonated and includes a negatively charged anion balancing the positively charged nitrogen atom.
11 more elements
Dependencies are inferred from the claim text.